CCR7, CCR8, CCR9 and CCR10 in the mouse hippocampal CA1 area and the dentate gyrus during and after pilocarpine-induced status epilepticus

Journal of Neurochemistry

Volumn 100, Issue 4, 2007, Pages 1072-1088

  Liu, Jian Xin ^a,b   Cao, Xia ^b,c   Tang, Yong Cheng ^b   Liu, Yong ^a   Tang, Feng Ru ^b,d  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CCR7 10; Epilepsy; Hippocampus; Status epilepticus

Indexed keywords

CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CCR9; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; PILOCARPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DENDRITE; DENTATE GYRUS; EPILEPTIC STATE; EPILEPTOGENESIS; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; INTERNEURON; MALE; MOSSY FIBER; MOUSE; NERVE FIBER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MICE; PILOCARPINE; RECEPTORS, CHEMOKINE; STATUS EPILEPTICUS; TIME FACTORS;

EID: 33846822073     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04272.x     Document Type: Article

References (54)

1. Araujo D. M. and Cotman C. W. (1993) Trophic effects of interleukin-4-7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res. 600, 49-55.
2. Arenberg D. A., Kunkel S. L., Polverini P. J., Glass M., Burdick M. D. and Strieter R. M. (1996) Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97, 2792-2802.
3. Bajetto A., Bonavia R., Barbero S., Florio T. and Schettini G. (2001) Chemokines and their receptors in the central nervous system. Front. Neuroendocrinol. 22, 147-184.
4. Berger E. A. (1997) HIV entry and tropism: the chemokine receptor connection. AIDS 11, S3-S16.
5. Berman J. W., Guida M. P., Warren J., Amat J. and Brosnan C. F. (1996) Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 156, 3017-3023.
6. Bjorkdahl O., Barber K. A., Brett S. J., Daly M. G., Plumpton C., Elshourbagy N. A., Tite J. P. and Thomsen L. L. (2003) Characterization of CC-chemokine receptor 7 expression on murine T cells in lymphoid tissues. Immunology 110, 170-179.
7. Brandt M. D., Jessberger S., Steiner B., Kronenberg G., Reuter K., Bick-Sander A., von der Behrens W. and Kempermann G. (2003) Transient calretinin expression defines early post-mitotic step of neuronal differentiation in adult hippocampal neurogenesis of mice. Mol. Cell. Neurosci. 24, 603-613.
8. Cartier J., Hartley O., Dubois-Dauphin M. and Krause K. H. (2005) Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Rev. 48, 16-42.
9. Chen J., Sochivko D., Beck H., Marechal D., Wiestler O. D. and Becker A. J. (2001) Activity-induced expression of common reference genes in individual CNS neurons. Lab. Invest. 81, 913-916.
10. Cho C. and Miller R. J. (2002) Chemokine receptors and neural function. J. Neurovirol. 8, 573-584.
11. Cocchi F., DeVico A. L., Garzino-Demo A., Arya S. K., Gallo R. C. and Lusso P. (1995) Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-1815.
12. Columba-Cabezas S., Serafini B., Ambrosini E. and Aloisi F. (2003) Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuro-inflammation. Brain Pathol. 13, 38-51.
13. Crespel A., Coubes P., Rousset M. C., Brana C., Rougier A., Rondouin G., Bockaert J., Baldy-Moulinier M. and Lerner-Natoli M. (2002) Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res. 952, 159-169.
14. Croitoru-Lamoury J., Guillemin G. J., Boussin F. D., Mognetti B., Gigout L. I., Cheret A., Vaslin B., Le Grand R., Brew B. J. and Dormont D. (2003) Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF α and IFN γ in CXCR4 and CCR5 modulation. Glia 41, 354-370.
15. Dorf M. E., Berman M. A., Tanabe S., Heesen M. and Luo Y. (2000) Astrocytes express functional chemokine receptors. J. Neuroimmunol. 111, 109-121.
16. Eugenin E. A., D'Aversa T. G., Lopez L., Calderon T. M. and Berman J. W. (2003) MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J. Neurochem. 85, 1299-1311.
17. Feng Y., Broder C. C., Kennedy P. E. and Berger E. A. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
18. Fischer F. R., Santambrogio L., Luo Y., Berman M. A., Hancock W.W. and Dorf M. E. (2000) Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression. J. Neuroimmunol. 110, 195-208.
19. Gillard S. E., Lu M., Mastracci R. M. and Miller R. J. (2002) Expression of functional chemokine receptors by rat cerebellar neurons. J. Neuroimmunol. 124, 6-28.
20. Giovannelli A., Limatola C., Ragozzino D., Mileo A. M., Ruggieri A., Ciotti M. T., Mercanti D., Santoni A. and Eusebi F. (1998) CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROa) modulate Purkinje neuron activity in mouse cerebellum. J. Neuroimmunol. 92, 122-132.
21. Gourmala N. G., Buttini M., Limonta S., Sauter A. and Boddeke H. W. (1997) Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration. J. Neuroimmunol. 74, 35-44.
22. Heinemann U., Gabriel S., Jauch R., Schulze K., Kivi A., Eilers A., Kovacs R. and Lehmann T. N. (2000) Alterations of glial cell function in temporal love epilepsy. Epilepsia 41, S185-S189.
23. Horuk R., Martin A. W., Wang Z. et al. (1997) Expression of chemokinereceptors in subsets of neurons in the central nervoussystem. J. Immunol. 158, 2882-2890.
24. Limatola C., Ciotti M. T., Mercanti D., Vacca F., Ragozzino D., Giovannelli A., Santoni A., Eusebi F. and Mildedi R. (2000) The chemokine growth-related gene product β protects rat cerebellar granule cells from apoptoticcell death through α-amino-3-hydroxy-5-methyl-4- isoxazolepropionate receptors. Proc. Natl Acad. Sci. USA 97, 6197-6201.
25. Ma D. L., Tang Y. C., Chen P. M., Chia S. C., Jiang F. L., Burgunder J. M., Lee W. L. and Tang F. R. (2006) Reorganization of CA3 area of the mouse hippocampus after pilocarpine induced temporal lobe epilepsy with special reference to the CA3-septum pathway. J. Neurosci. Res. 83, 318-331.
26. Meucci O., Fatatis A., Simen A. A., Bushell T. J., Gray P. W. and Miller R. J. (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl Acad. Sci. USA 95, 14 500-14 505.
27. Nuovo G. J. and Alfieri M. L. (1996) AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol. Med. 2, 358-366.
28. Olimpia M., Fatatis A., Simen A. A., Bushell T. J., Gray P. W. and Miller J. R. (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl Acad. Sci. USA 95, 14500-14505.
29. Olimpia M., Fatatis A., Simen A. A. and Miller R. J. (2000) Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal surivival. Proc. Natl Acad. Sci. USA 97, 8075-8080.
30. Puma C., Danick M., Quirion R., Ramon F. and Williams S. (2001) The chemokine interlukin-8 acutely reduces Ca2+ currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J. Neurochem. 78, 960-971.
31. Ransohoff R. M., Hamilton T. A., Tani M., Stoler M. H., Shick H. E., Major J. A., Estes M. L., Thomas D. M. and Tuohy V. K. (1993) Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7, 592-600.
32. Represa A., Niquet J., Pollard H. and Ben-Ari Y. (1995) Cell death, gliosis and synaptic remodeling in the hippocampus of epileptic rats. J. Neurobiol. 26, 413-425.
33. Rice A. C., Floyd C. L., Lyeth B. G., Hamm R. J. and DeLorenzo R. J. (1998) Status epilepticus causes long-term NMDA receptordependent behavioral changes and cognitive deficits. Epilepsia 39, 1148-1157.
34. Rice A. C. and DeLorenzo R. J. (1999) N-methyl-D- aspartate receptor activation regulates refractoriness of status epilepticus to diazepam. Neuroscience 93, 117-123.
35. Rucker J., Edinger A. L., Sharron M. et al. (1997) Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 71, 8999-9007.
36. Sambrook J., Fritsch E. F. and Gething M. J. (1989) Molecular Cloning: A Laboratory Manual, pp. 1.82-1.84. Cold Spring Harbor Laboratory Press, New York.
37. Schroder W., Hinterkeuser S., Seifert G., Schramm J., Jabs R., Wilkin G. P. and Steinhauser C. (2000) Functional and molecular properties of human astrocytes in acute hippocampal slices obtained from patients with temporal lobe epilepsy. Epilepsia 41, S181-S184.
38. Sorensen T. L., Tani M., Jensen J. et al. (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103, 807-815.
39. Spleiss O., Gourmala N., Boddeke H. W., Sauter A., Fiebich B. L., Berger M. and Gebicke-Haerter P. J. (1998) Cloning of rat HIV-1-chemokine coreceptor CKR5 from microglia and upregulation of its mRNA in ischemic and endotoxinemic rat brain. J. Neurosci. Res. 53, 16-28.
40. Tang F. R. (2005) Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents? Curr. Neuropharmacol. 3, 299-307.
41. Tang F. R., Chia S. C., Chen P. M., Gao H., Lee W. L., Yeo T. S., Burgunder J. M., Probst A., Sim M. K. and Ling E. A. (2004a) Metabotropic glutamate receptor2/3 in the hippocampus of patients with mesial temporal lobe epilepsy, of rats and mice after pilocarpine-induced status epilepticus. Epilepsy Res. 59, 167-180.
42. Tang F. R., Lee W. L., Gao H., Chen Y., Loh Y. T. and Chia S. C. (2004b) Expression of different isoforms of protein kinase C in the rat hippocampus after pilocarpine induced status epilepticus with special reference to CA1 area and the dentate gyrus. Hippocampus 14, 87-98.
43. Tang F. R., Chia S. C., Zhang S., Chen P. M., Gao H., Liu C. P., Khanna S. and Lee W. L. (2005) Glutamate receptor 1 immunopositive neurons in the gliotic CA1 area of the mouse hippocampus after pilocarpine induced status epilepticus. Eur. J. Neurosci. 21, 2361-2374.
44. Tang F. R., Chia S. C., Jiang F. L., Ma D. L., Chen P. M. and Tang Y. C. (2006) Calcium binding protein containing neurons in the gliotic mouse hippocampus with special reference to their afferents from the medial septum and the entorhinal cortex. Neuroscience 140, 1467-1479.
45. Trebst C., Staugaitis S. M., Kivisakk P. et al. (2003) CC chemokine receptor 8 in the central nervous system is associated with phagocytic macrophages. Am. J. Pathol. 162, 427-438.
46. Umehara F., Izumo S., Takeya M., Takahashi K., Sato E. and Osame M. (1996) Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol. (Berl.) 91, 343-350.
47. Van Der Voorn P., Tekstra J., Beelen R. H., Tensen C. P., Van Der Valk P. and De Groot C. J. (1999) Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am. J. Pathol. 154, 45-51.
48. Van Gassen K. L., Netzeband J. G., Graan de P. N. and Gruol D. L. (2005) The chemokine CCL2 modulates Ca2+ dynamics and electrophysiological properties of cultured cerebellar Purkinje neurons. Eur. J. Neurosci. 21, 2949-2957.
49. Watson K. and Fan G. H. (2005) Macrophage inflammatory protein 2 inhibits b-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Mol. Pharmacol. 67, 757-765.
50. White H. S. (2003) Preclinical development of anti-epileptic drugs: past, present, and future directions. Epilepsia 44, 2-8.
51. Wu C. L., Huang L. T., Liou C. W., Wang T. J., Tung Y. R., Hsu H. Y. and Lai M. C. (2001) Lithium-pilocarpine-induced status epilepticus in immature rats result in long-term deficits in spatial learning and hippocampal cell loss. Neurosci. Lett. 312, 113-117.
52. Xia M. Q., Qin S. X., Wu L. J., Mackay C. R. and Hyman B. T. (1998) Immunohistochemical study of the β-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am. J. Pathol. 153, 31-37.
53. Xia M. Q., Bacskai B. J., Knowles R. B., Qin S. X. and Hyman B. T. (2000) Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease. J. Neuroimmunol. 108, 227-235.
54. Zaballos A., Gutierrez J., Varona R., Ardavin C. and Marquez G. (1999) Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J. Immunol. 162, 5671-5675.